Big Pharma

Allergan faces a <strong><a href="http://www.courthousenews.com/wp-content/uploads/2017/03/actavis.pdf">federal class action</a> </strong>alleging that the pharmaceutical giant's two retirement plans wasted assets by buying inflated Allergan stock.

NEWARK, N.J. – Allergan, the pharmaceutical giant previously known as Actavis, faces a federal class action alleging that two retirement plans wasted assets by buying inflated Allergan stock.

Categories / Employment, Securities

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.